Pathology, Diagnosis, and Treatments of Airway Diseases
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: 1 October 2026 | Viewed by 53
Special Issue Editors
Interests: airway diseases; asthma; immunology; allergy; biomarkers
Special Issues, Collections and Topics in MDPI journals
Interests: severe asthma; biologics; biomarkers; airway diseases
Special Issue Information
Dear Colleagues,
Airway diseases encompass a heterogeneous group of disorders, including asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and respiratory infections, which are considered among the leading causes of morbidity and mortality worldwide.
The diagnosis and management of airway diseases represent a significant challenge for clinicians due to the incomplete understanding of their pathogenesis and the variability in patients’ response to first-line therapies.
In recent decades, cutting-edge technologies have deepened our knowledge of the pathophysiological and molecular mechanisms underlying these conditions, paving the way for novel targeted approaches.
Unravelling the genetic roots, molecular pathways, and environmental factors guiding airway disease development and prognosis is crucial to improving patient outcomes.
This Special Issue aims to provide an up-to-date, comprehensive overview of the pathogenesis of airway diseases, while exploring emerging diagnostic and therapeutic approaches that may shape the future of respiratory healthcare.
Dr. Laura Bergantini
Guest Editor
Dr. Tommaso Pianigiani
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- airway diseases
- COPD
- asthma
- cystic fibrosis
- bronchiectasis
- biomarkers
- biologics
- targeted
- immunology
- pathogenesis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
